ACC |
Acetyl-CoA carboxylase |
AES |
Androgen excess society |
ALT |
Alanine aminotransferase |
AST |
Aspartate aminotransferase |
BMI |
Body mass index |
COCs |
Combined oral contraceptives |
CVD |
Cardiovascular disease |
CYP17 |
Cytochrome P450 family 17 |
DHEAS |
Dehydroepiandrosterone sulfate |
DNL |
De novo lipogenesis |
FSH |
Follicle-stimulating hormone |
GGT |
γ-Glutamyl transferase |
GLUT |
Glucose transport |
GnRH |
Gonadotropin-releasing hormone |
HDL-C |
High-density lipoprotein-cholesterol |
HFD |
High fat diet |
HepG2 |
Hepatoma cell |
HNF-4α |
Hepatocyte nuclear factor 4 α |
HOMA-IR |
Homeostatic model assessment for insulin resistance |
IGT |
Impaired glucose tolerance |
IRS |
Insulin receptor substrate |
IL-1β |
Interleukin-1β |
IR |
Insulin resistance |
LDL |
Low-density lipoprotein |
LH |
Luteinizing hormone |
JNK |
JNK c-Jun N-terminal kinase |
MAPK |
Mitogen-activated protein kinases |
MEK-1/2 |
Methyl ethyl ketone-1/2 |
NAFLD |
Non-alcoholic fatty liver disease |
NASH |
Non-alcoholic steatohepatitis |
NEFAs |
Non-esterified fatty acids |
NF-kB |
Nuclear factor-kB |
NIH |
National Institutes of Health |
NR |
Normal range |
PCOS |
Polycystic ovary syndrome |
PCOM |
Polycystic ovary morphology |
PI3Kp85a |
Phosphoinositide 3 kinase, p85 α |
PPAR-γ |
Peroxisome proliferator-activated receptor-γ |
SHBG |
Sex hormone-binding globulin |
SREBP-1c |
Sterol regulatory element binding protein 1c |
T2DM |
Type 2 diabetes mellitus |
TNF-α |
Tumor necrosis factor-α |